Palliative care clinical practice guidelines in oncology

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 4, Issue 8, 2006, Pages 776-818

  Levy, Michael H ^a   Back, Anthony ^b   Bazargan, Sadaf ^c   Benedetti, Costantino ^d   Billings, J Andrew ^e   Block, Susan ^e   Bruera, Eduardo ^f   Carducci, Michael A ^g   Dy, Sydney ^h   Eberle, Catherine ^h   Foley, Kathleen M ⁱ   Harris, Juan Diego ^j   Knight, Sara J ^k   Milch, Robert ^l   Rhiner, Michelle ^m   Slatkin, Neal E ^m   Spiegel, David ⁿ   Sutton, Linda ^o   Urba, Susan ^p   Von Roenn, Jamie H ^q   Weinstein, Sharon M ^r   more..

^a FOX CHASE CANCER CENTER   (United States)

^b SEATTLE CANCER CARE ALLIANCE   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e Dana Farber/Partners CancerCare   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g JOHNS HOPKINS UNIVERSITY   (United States)

^h NEBRASKA MEDICAL CENTER   (United States)

ⁱ MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^j ROSWELL PARK CANCER INSTITUTE   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l Center for Hospice and Palliative Care   (United States)

^m City of Hope Cancer Center   (United States)

ⁿ STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^o DUKE CANCER INSTITUTE   (United States)

^p UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^q NORTHWESTERN UNIVERSITY   (United States)

^r UNIVERSITY OF UTAH   (United States)

more..

Author keywords

Cancer treatment; Death and dying; End of life issues; Hospice care; NCCN Clinical Practice Guidelines; Palliative care

Indexed keywords

ANTIBIOTIC AGENT; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE; BISACODYL; BRONCHODILATING AGENT; CANNABINOID; CARBAMAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DEXAMETHASONE; DIGOXIN; DIURETIC AGENT; DOCUSATE SODIUM; GLYCEROL; HALOPERIDOL; LACTULOSE; LAXATIVE; MECLOZINE; METOCLOPRAMIDE; MINERAL OIL; ONDANSETRON; OPIATE; PHENYTOIN; PROCHLORPERAZINE; PROTON PUMP INHIBITOR; SCOPOLAMINE; SEROTONIN 3 ANTAGONIST; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

ACUPUNCTURE; ANOREXIA; ANXIETY DISORDER; CACHEXIA; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RISK; CANCER SCREENING; CLINICAL PRACTICE; CLINICAL TRIAL; CONSTIPATION; DEATH; DELIRIUM; DYSPNEA; EXERCISE; HEALTH PROGRAM; HUMAN; INTESTINE OBSTRUCTION; LIFE EXPECTANCY; MEDICAL ASSESSMENT; MEDICAL SPECIALIST; NAUSEA AND VOMITING; NUTRITION EDUCATION; OXYGEN THERAPY; PATIENT CARE; PATIENT EDUCATION; PATIENT INFORMATION; PATIENT SATISFACTION; PRACTICE GUIDELINE; PSYCHOSOCIAL DISORDER; QUALITY OF LIFE; REVIEW; RISK BENEFIT ANALYSIS; SEDATION; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 33748792011     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2006.0068     Document Type: Review

References (57)

1. ASCO Task Force for Cancer Care at the End of Life. Cancer care during the last phase of life. J Clin Oncol 1998;16:1986-1996.
2. Berger A, Portenoy RK, Weissman DE, eds. Practice and Principles of Supportive Oncology. Philadelphia: Lippincott-Raven; 1998.
3. Doyle D, Hanks OW, MacDonald N, eds. Oxford Textbook of Palliative Medicine. Oxford, UK: Oxford University; 1998.
4. Emanuel LL, von Gunten CF, Ferris FD. The Education for Physicians on End-of-Life Care (EPEC) Curriculum. Princeton, NJ: The Robert Wood Johnson Foundation; 1999.
5. Jemal A, Siegel R, Ward E, et al. Cancer Statistics, 2006. CA Cancer J Clin 2006;56:106-130.
6. Levy MH. Living with cancer: hospice/palliative care. J Natl Cancer Inst 1993;85:1283-1287.
7. Levy MH, ed. Supportive oncology. Semin Oncol 1994;21:699-798.
8. MacDonald N. Palliative care-the fourth phase of cancer prevention. Cancer Detect Prev 1991;15:253-255.
9. Cancer Pain Relief and Palliative Care: Report of a WHO Expert Committee. Geneva: World Health Organization; 1990.
10. Elsayem A, Swint K, Fisch MJ, et al. Palliative Care inpatient service in a comprehensive cancer center: clinical and financial outcomes. J Clin Oncol 2004;22:2008-2011.
11. Earle CC, Neville BA, Landrum MB, et al. Trends in the aggressiveness of cancer care the end of life. J Clin Oncol 2004;22:315-321.
12. Foley KM, Gelband H. Improving palliative care for cancer. Washington, DC: National Academy Press; 2001.
13. Malin JL. Bridging the divide: integrating cancer-directed therapy and palliative care. J Clin Oncol 2004;22:3438-3440.
14. The SUPPORT Principal Investigators. A controlled trial to improve care for seriously ill hospitalized patients: the study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). JAMA 1995;274:1591-1598.
15. Field MJ, Cassel CK, eds. Approaching Death: Improving Care at the End of Life. Washington, DC: National Academy Press, 1997.
16. Meyers FJ, Linder J. Simultaneous care: disease treatment and palliative care throughout illness. J Clin Oncol 2003;21:1412-1415.
17. Davis MP. Integrating palliative medicine into an oncology practice. Am J Hosp Palliat Care 2005;22:447-456.
18. Levy MH. NCCN Task Force reports: supportive and palliative care. Oncology 1999;13:517-522.
19. Weissman DE. Decision making at a time of crisis near the end of life. JAMA 2004;292:1738-1743.
20. Kim A, Fall P, Wang D. Palliative care: optimizing quality of life. J Am Osteopath Assoc 2005;105(suppl 5):S9-S14.
21. Chochinov HM. Dying, dignity, and new horizons in palliative end-of-life care. CA Cancer J Clin 2006;56:84-103.
22. de Haes H, Teunissen S. Communication in palliative care: a review of recent literature. Curr Opin Oncol 2005;17:345-350.
23. Sinclair CT. Communicating a prognosis in advanced cancer. J Support Oncol 2006;4:201-204.
24. National Institutes of Health. National Institutes of Health State-of-the-Science Conference: Statement on Improving End-of-Life Care. Available at: http://consensus.nih.gov/2004/2004EndOfLifeCare SOS024html.htm. Accessed July 5, 2006.
25. Lorenz KA, Lynn J, Morton SC, et al. Methodological approaches for a systematic review of end-of-life care. J Palliat Med 2005; 8(suppl 1):S4-S11.
26. National Consensus Project for Quality Palliative Care (2004). Clinical practice guidelines for quality palliative care. Available at: http://www.nationalconsensusproject.org. Accessed July 5, 2006.
27. National Institute for Clinical Excellence. Supportive and palliative care. Available at: http://www.nice.org.uk/page.aspx?o=csgsp. Accessed July 6, 2006.
28. Singer PA, Martin DK, Keiner M. Quality end-of-life care: patients' perspectives. JAMA 1999;281:163-168.
29. Levy MH. Supportive oncology-palliative care: what's in a name? Semin Oncol 2005;32:131-133.
30. Khatcheressian J, Cassel JB, Lyckholm L, et al. Improving palliative and supportive care in cancer patients. Oncology (Williston Park) 2005;19:1365-1376.
31. Morrison R, Meier D. Palliative care. N Engl J Med 2004;350:2582-2590.
32. Weeks JC, Cook EF, O'Day SJ, et al. Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA 1998;279:1709-1714.
33. Lo B, Ruston D, Kates LW, et al. Discussing religious and spiritual issues at the end of life: a practical guide for physicians. JAMA 2002;287:749-754.
34. Prommer E. Guidelines for the use of palliative chemotherapy. AAHPM Bull 2004;5:2-13.
35. Pienta KJ, Smith DC. Advances in prostate cancer chemotherapy: a new era begins. CA Cancer J Clin 2005;55:300-318.
36. Guarneri V, Conte P. The curability of breast cancer and the treatment of advanced disease. Eur J Nucl Med Mol Imaging 2004; 31(suppl 1):S149-S161.
37. Freelove R, Walling AD. Pancreatic cancer: diagnosis and management. Am Fam Physician 2006;73:485-492.
38. Ajani JA. Evolving chemotherapy for advanced gastric cancer. Oncologist 2005;10(suppl 3):49-58.
39. Brown J, Thorpe H, Napp V, et al. Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancer. J Clin Oncol 2005;23:7417-7427.
40. Silvestri GA, Rivera PM. Targeted therapy for the treatment of advanced non-small cell lung cancer: a review of the epidermal growth factor receptor antagonists. Chest 2005;128:3975-3984.
41. Kinzbrunner BM. Hospice: what to do when anti-cancer therapy is no longer appropriate, effective, or desired. Semin Oncol 1994;21:792-798.
42. Temel JS, Pirl WF, Lynch TJ. Comprehensive symptom management in patients with advanced-stage non-small-cell lung cancer. Clin Lung Cancer 2006;7:241-249.
43. Laviano A, Meguid MM, Inui A, et al. Therapy insight: cancer anorexia-cachexia syndrome-when all you can eat is yourself. Nat Clin Pract Oncol 2005;2:158-165.
44. Schwartzberg L. Chemotherapy-induced nausea and vomiting: state of the art in 2006. J Support Oncol 2006;4(suppl 1):3-8.
45. Grossman S, Benedetti C, Payne R, et al. NCCN practice guidelines for cancer pain. Oncology 1999;13:33-44.
46. Mock V, Atkinson A, Barsevick A, et al. Cancer-Related Fatigue NCCN Clinical Practice Guidelines in Oncology™. JNCCN 2003;1:308-331.
47. Holland JC, Andersen B, Booth-Jones M, et al. Distress Management NCCN Clinical Practice Guidelines in Oncology™. JNCCN 2003;1:344-374.
48. Elsayem AF, Jenkins R, Parmley L, et al. The impact of a palliative care service on overall hospital mortality in a comprehensive cancer center {Abstract.} J Clin Oncol 2004;22(14 suppl):8034.
49. Han B, Remsburg RE, McAuley WJ, et al. National trends in adult hospice use: 1991-1992 to 1999-2000. Health Aff (Millwood) 2006;25:792-799.
50. Levy MH, Cohen SC. Sedation for the relief of refractory symptoms in the imminently dying: a fine intentional line. Semin Oncol 2005;32:237-246.
51. Wein S. Sedation in the imminently dying patient. Oncology (Williston Park) 2000;14:585-592.
52. Cowan JD, Palmer TW. Practical guide to palliative sedation. Curr Oncol Rep 2002;4:242-249.
53. Cherny NI, Portenoy RK. Sedation in the management of refractory symptoms: guidelines for evaluation and treatment. J Palliat Care 1994;10:31-38.
54. Braun TC, Hagen NA, Clark T. Development of a clinical practice guideline for palliative sedation. J Palliat Med 2003;6:345-350.
55. Byock I. Dying Well: The Prospect for Growth at the End of Life. New York: Riverhead Books; 1997.
56. Hartmann LC. Unrealistic expectations. J Clin Oncol 2005;23:4231-4232.
57. Kalemkerian GP. Commentary on "Unrealistic Expectations." J Clin Oncol 2005;23:4233-4234.